Latest news and updates about the Medicare and pharmacy industries.

What GERs Mean For Pharmacies

Posted on in Industry Updates by Amplicare Team

In recent months, generic effective rate (GER) clauses in pharmacy contracts have taken center stage as pharmacists become more aware of what exactly this means for them. Though not new, in recent years, GERs have become tighter and more restrictive, leading to the potential for unexpectedly high clawbacks by PBMs at the end of a contract year. Such clauses have shown up in several contracts so far this year, indicating a trend which pharmacists would do well to pay attention to.

As contracts are typically brokered between PSAOs and PBMs, not every pharmacy is or will be affected by GERs. With that in mind, here’s what you need to know about GERs and how they can affect your business.

Transparency Was A Key Theme at the PBM Senate Hearing

Posted on in Industry Updates by admin

Last week, executives from the five largest PBMs — CVS Health, Cigna, Prime Therapeutics, Humana, and UnitedHealthcare’s OptumRx — appeared at a Senate Finance Committee hearing to discuss their roles in pharmaceutical supply chain. The high price of prescription drugs has become a rare bipartisan issue.

Amplicare Spotlight: Iuka’s Chris Cornelison on Driving Front-End Growth at His Pharmacy

Posted on in Other by admin

To stay competitive, pharmacies often expand their focus beyond prescriptions to the benefit of both their patients and their bottom lines. In this Q&A, Chris Cornelison, Pharm.D, owner of Iuka Discount Drugs, Saltillo Pharmacy and Solutions, New Albany Pharmacy, and Solutions Rx sheds light on his pharmacy’s experiences with OTC proucts. Read on to see how he educates patients about supplements, how his patients have responded to CBD products, and what he sees driving front-end growth at pharmacies.

April 5: New Part D Policies Address Opioid Crisis, FDA to Hold Public Hearing on CBD, and More

Posted on in Industry Updates by admin

Here’s the latest in the world of pharmacy and healthcare:

1. The FDA wants to hear stakeholder experiences with CBD products.

2. The global telemedicine market will hit $130.5 billion by 2025.

3. CMS has introduced new policies to help fight the opioid crisis.

4. CMS has also finalized payment updates to Medicare and Part D plans for 2020.

5. Medicare customers are increasingly looking online for their plans.

Page 1 of 3